Curr Diab Rep 7(6):443448
Blue Cross Blue Shield of Michigan GLP-1 Coverage Changes Explained Understanding the New Coverage Changes As of August 1, 2024, Blue Cross Blue Shield of Michigan (BCBSM) and Blue Care Network (BCN) are altering their coverage for GLP-1 receptor agonists, which include popular weight loss medications like Saxenda (liraglutide), Wegovy (semaglutide), and Zepbound (tirzepatide)
The Florida Board of Medicine's anti-obesity drug rule does require re-evaluation at least every three months for patients on chronic weight-management medications most reputable telehealth providers, including PlexusDx, build that cadence into the protocol
Mahmoud MF, Ali N, Mahdi I, Mouhtady O, Mostafa I, El-Shazly AM, et al
Khanduri, U., & Sharma, A